Risk of rapid evolutionary escape from biomedical interventions targeting SARS-CoV-2 spike protein.
The spike protein receptor-binding domain (RBD) of SARS-CoV-2 is the molecular target for many vaccines and antibody-based prophylactics aimed at bringing COVID-19 under control. Such a narrow molecular focus raises the specter of viral immune evasion as a potential failure mode for these biomedical...
Na minha lista:
| Principais autores: | , , , , , , , , , , |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Public Library of Science (PLoS)
2021-01-01
|
| 叢編: | PLoS ONE |
| 在線閱讀: | https://doi.org/10.1371/journal.pone.0250780 |
| 標簽: |
沒有標簽, 成為第一個標記此記錄!
|
